Balyasny Asset Management LLC G1 Therapeutics, Inc. Transaction History
Balyasny Asset Management LLC
- $54.8 Billion
- Q1 2024
A detailed history of Balyasny Asset Management LLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 15,614 shares of GTHX stock, worth $57,303. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,614Holding current value
$57,303% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding GTHX
# of Institutions
96Shares Held
14.7MCall Options Held
631KPut Options Held
347K-
Vanguard Group Inc Valley Forge, PA2.08MShares$7.64 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA951KShares$3.49 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny904KShares$3.32 Million0.01% of portfolio
-
Raymond James & Associates St Petersburg, FL798KShares$2.93 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY785KShares$2.88 Million0.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $157M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...